Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review

Bibliography

• Maestroni GJM, Covacci V, Conti A. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res 1994;54:2429-32
   PubMed Web of Science ®Google Scholar
• Sainz RM, Mayo JC, Rodriguez C, et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003;60:1407-26
   PubMed Web of Science ®Google Scholar
• Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, et al. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 2010;17:4462-81
   PubMed Web of Science ®Google Scholar
• Uguz AC, Cig B, Espino J, et al. Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells. J Pineal Res 2012;53:91-8
   PubMed Web of Science ®Google Scholar
• Kim JH, Jeong SJ, Kim B, et al. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells. J Pineal Res 2012;52:244-52
   PubMed Web of Science ®Google Scholar
• Rodriguez-Garcia A, Mayo JC, Hevia D, et al. Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis. J Pineal Res 2013;54:35-45
   Google Scholar
• Jung B, Ahmad N. Melatonin in cancer management: progress and promise. Cancer Res 2006;66:9789-93
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010;181:127-51
   PubMed Web of Science ®Google Scholar
• Sánchez-Hidalgo M, Guerrero JM, Villegas I, et al. Melatonin, a natural programmed cell death inducer in cancer. Curr Med Chem 2012;19:3805-21
   Google Scholar
• Stehle JH, Saade A, Rawashdeh O, et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011;17-43
   Google Scholar
• Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009;44:175-200
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Rosales-Corral S. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 2013;13:373-84
   PubMed Web of Science ®Google Scholar
• Barrett P, Bolborea M. Molecular pathways involved in seasonal body weight and reproductive responses governed by melatonin. J Pineal Res 2012;52:376-88
   PubMed Web of Science ®Google Scholar
• Agez L, Laurent V, Pevet P, et al. Melatonin affects nuclear orphan receptors mRNA in the rat suprachiasmatic nuclei. Neuroscience 2007;144:522-30
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008;85:335-53
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Manchester LC, et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007;52:11-28
   PubMed Web of Science ®Google Scholar
• Hardeland R, Cardinali DP, Srinivasan V, et al. Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 2011;93:350-84
   PubMed Web of Science ®Google Scholar
• Sainz RM, Mayo JC, Tan DX, et al. Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 2005;63:29-43
   PubMedGoogle Scholar
• Martín V, Herrera F, Carrera-Gonzalez P, et al. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res 2006;66:1-8
   Google Scholar
• Sánchez-Sánchez AM, Martín V. García-Santos, G, et al. Intracellular redox state as determinant for melatonin antiproliferative vs. cytotoxic effects in cancer cells. Free Radic Res 2011;45:1333-41
   PubMed Web of Science ®Google Scholar
• Sainz RM, Mayo JC, Tan DX, et al. Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation. Biochem Bioph Res Commun 2003;302:625-34
   Google Scholar
• Farriol M, Venereo Y, Orta X, et al. In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line. J Appl Toxicol 2000;20:21-4
   Web of Science ®Google Scholar
• Kojima T, Mochizuki C, Mitaka T, Mochizuki Y. Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes. Cell Struct Funct 1997;22:347-56
   PubMed Web of Science ®Google Scholar
• Cui P, Yu M, Luo Z, et al. Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. J Pineal Res 2008;44:107-14
   PubMed Web of Science ®Google Scholar
• Baldwin WS, Travlos GS, Risinger JI, Barrett JC. Melatonin does not inhibit estradiol-stimulated proliferation in MCF-7 and BG-1 cells. Carcinogenesis 1998;19:1895-900
   PubMedGoogle Scholar
• Shellar DA, Whelanb RD, Hill T. Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. Br J Cancer 1989;60:288-90
   Google Scholar
• Cucina A, Proietti S, D'Anselmi F, et al. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J Pineal Res 2009;46:172-80
   PubMed Web of Science ®Google Scholar
• Proietti S, Cucina A, D'Anselmi F, et al. Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res 2011;50:150-8
   PubMed Web of Science ®Google Scholar
• Jung-Hynes B, Schmit TL, Reagan-Shaw SR, et al. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res 2011;50:140-9
   PubMed Web of Science ®Google Scholar
• Davis S, Mirick DK. Circadian disruption, shift work, and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006;17:539-45
   PubMed Web of Science ®Google Scholar
• Vijayalaxmi Thomas CR Jr, Reiter RJ, Herman TS. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575-601
   PubMed Web of Science ®Google Scholar
• Ram PT, Yuan L, Dai J, et al. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin. J Pineal Res 2000;28:210-18
   PubMedGoogle Scholar
• Helton RA, Harrison WA, Kelley K, Kane MA. Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res 1993;3:403-13
   PubMed Web of Science ®Google Scholar
• Mengeaud V, Skene D, Pévet P, Ortonne JP. No high affinity melatonin binding sites are detected in murine melanoma cells and in normal human melanocytes cultured in vitro. Melanoma Res 1994;4:87-91
   Google Scholar
• Cos S, Garcia-Bolado A, Sánchez-Barceló EJ. Direct antiproliferative effects of melatonin on two metastatic cell sublines of mouse melanoma (B16BL6 and PG19). Melanoma Res 2001;11:197-201
   Google Scholar
• Cos S, Sanchez-Barcelo EJ. Melatonin inhibition of MCF-7 human breast-cancer cells growth: Influence of cell proliferation rate. Cancer Lett 1995;93:207-12
   PubMed Web of Science ®Google Scholar
• Cos S, Blask DE. Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system. Cancer Lett 1990;50:115-19
   Google Scholar
• Bizzarri M, Pasqualato A, Cucina A, Pasta V. Physical forces and non linear dynamics mould fractal cell shape. Histol Histopathol 2013;28:155-74
   PubMed Web of Science ®Google Scholar
• Bizzarri M, Cucina A, Valente MG, et al. Melatonin and vitamin D3 increase TGF-beta1 release and induce growth inhibition in breast cancer cell cultures. J Surg Res 2003;110:332-7
   PubMed Web of Science ®Google Scholar
• Radogna F, Paternoster L, Albertini MC, et al. Melatonin as an apoptosis antagonist. Ann NY Acad Sci 2006;1090:226-33
   Google Scholar
• Bonmati-Carrion MA, Álvarez-Sánchez N, Hardeland R, et al. A Comparison of B16 melanoma cells and 3T3 fibroblasts concerning cell viability and ROS production in the presence of melatonin, tested over a wide range of concentrations. Int J Mol Sci 2013;14:3901-20
   PubMed Web of Science ®Google Scholar
• Fischer TW, Zmijewski MA, Zbytek B, et al. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 2006;29:665-72
   PubMed Web of Science ®Google Scholar
• Cos S, Blask DE. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells. J Pineal Res 1994;17:25-32
   Google Scholar
• Blask DE, Hill SM. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm 1986;21:433-49
   Google Scholar
• Lemus-Wilson A, Kelly PA, Blask DE. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br J Cancer 1995;72:1435-40
   Google Scholar
• Sze SF, Ng TB, Liu WK. Antiproliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 1993;14:27-33
   PubMed Web of Science ®Google Scholar
• von Angerer E, Knebel N, Kager M, Ganss B. 1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists. J Med Chem 1990;33:2635-40
   Google Scholar
• Danforth DN Jr, Tamarkin L, Lippman ME. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature 1983;305:323-5
   PubMed Web of Science ®Google Scholar
• L'Hermite-Balériaux M, de Launoit Y. Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation? In Vitro Cell Dev Biol 1992;28A:583-4
   PubMedGoogle Scholar
• Rodriguez C, Martin V, Herrera F, et al. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int J Mol Sci 2013;14:6597-613
   Web of Science ®Google Scholar
• Trubiani O, Recchioni R, Moroni F, et al. Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation. J Pineal Res 2005;39:425-31
   PubMed Web of Science ®Google Scholar
• Bejarano I, Redondo PC, Espino J, et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009;46:392-400
   PubMed Web of Science ®Google Scholar
• Rubio S, Estévez F, Cabrera J, et al. Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J Pineal Res 2007;42:131-8
   PubMed Web of Science ®Google Scholar
• Koh W, Jeong SJ, Lee HJ, et al. Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5'-adenosine monophosphate-activated kinase-alpha in human leukemia HL-60 cells. J Pineal Res 2011;50:367-73
   Google Scholar
• Casado-Zapico S, Martín V, García-Santos G, et al. Regulation of the expression of death receptors and their ligands by melatonin in hematological cancer cell lines and in leukemia cells from patients. J Pineal Res 2011;50:345-55
   PubMed Web of Science ®Google Scholar
• Perdomo J, Cabrera J, Estévez F, et al. Melatonin induces apoptosis through a caspase-dependent but reactive oxygen species-independent mechanism in human leukemia Molt-3 cells. J Pineal Res 2013; In press
   Google Scholar
• Sànchez-Hidalgo M, Lee M, de la Lastra CA, et al. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines. J Pineal Res 2012;53:366-73
   Google Scholar
• Sanchez-Barcelo EJ, Cos S, Fernandez R, Mediavilla MD. Melatonin and mammary cancer: a short review. Endocr Relat Cancer 2003;10:153-9
   PubMed Web of Science ®Google Scholar
• Proietti S, Cucina A, Reiter RJ, Bizzarri M. Molecular mechanisms of melatonin's inhibitory actions on breast cancers. Cell Mol Life Sci 2013;70:2139-57
   PubMed Web of Science ®Google Scholar
• Cos S, Mediavilla MD, Fernandez R, et al. Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 2002;32:90-6
   PubMed Web of Science ®Google Scholar
• Czeczuga-Semeniuk E, Wolczynski S, Anchim T, et al. Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7. Pol J Pathol 2002;53:59-65
   PubMedGoogle Scholar
• Eck-Enriquez KM, Yuan L, Duffy L, et al. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br J Cancer 1998;77:2129-37
   Google Scholar
• Eck-Enriquez KM, Kiefer TL, Spriggs LL, Hill SM. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat 2000;61:229-39
   PubMedGoogle Scholar
• Nowfar S, Teplitzky SR, Melancon K, et al. Tumor prevention by 9-cisretinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res Treat 2002;72:33-43
   Google Scholar
• Abd El-Aziz MA, Hassan HA, Mohamed MH, et al. The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: an animal model. Int J Exp Path 2005;86:383-96
   Google Scholar
• Mediavilla MD, Cos S, Sànchez-Barcelò EJ. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 1999;65:415-20
   PubMed Web of Science ®Google Scholar
• Wang J, Xiao X, Zhang Y, et al. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J Pineal Res 2012;53:77-90
   PubMed Web of Science ®Google Scholar
• Blask DE, Brainard GC, Dauchy RT, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005;65:11174-84
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Brainard GC, Hanifin JP. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr Cancer Ther 2009;8:347-53
   PubMed Web of Science ®Google Scholar
• Marelli MM, Limonta P, Maggi R, et al. Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells. Prostate 2000;45:238-44
   PubMed Web of Science ®Google Scholar
• Moretti RM, Marelli MM, Maggi R, et al. Antiproliferative action of melatonin on human prostate cancer LNCaP cells. Oncol Rep 2000;7:347-51
   PubMedGoogle Scholar
• Tam CW, Mo CW, Yao K, Shiu SY. Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention. J Pineal Res 2007;42:191-202
   Google Scholar
• Benitez-King G. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 2006;40:1-9
   PubMed Web of Science ®Google Scholar
• Sampson SR, Lupowitz Z, Braiman L, Zisapel N. Role of protein kinase C-alpha in melatonin signal transduction. Mol Cell Endocrinol 2006;252:82-7
   PubMed Web of Science ®Google Scholar
• Gonzalez-Guerrico AM, Kazanietz MG. Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade. J Biol Chem 2005;280:38982-91
   Google Scholar
• Joo SS, Yoo YM. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res 2009;47:8-14
   PubMed Web of Science ®Google Scholar
• Kim CH, Yoo YM. Melatonin induces apoptotic cell death via p53 in LNCaP cells. Korean J Physiol Pharmacol 2010;14:365-9
   Google Scholar
• Bubenik GA, Brown GM. Pinealectomy reduces melatonin levels in the serum but not in the gastrointestinal tract of rats. Biol Signals 1997;6:40-4
   PubMedGoogle Scholar
• Chen CQ, Fichna J, Bashashati M, et al. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol 2011;17:3888-98
   PubMed Web of Science ®Google Scholar
• Callaghan BD. The long-term effect of pinealectomy on the crypts of the rat gastrointestinal tract. J Pineal Res 1995;18:191-6
   Google Scholar
• Callaghan BD. The effects of pinealectomy on the crypts of defunctioned rat colon. J Pineal Res 1997;23:117-22
   Google Scholar
• Anisimov VN, Popovich IG, Zabezhinski M. Melatonin and colon carcinogenesis. Inhibitory effects of melatonin on development of intestinal tumors induced by 1,2-dimethylhidrazyne in rats. Carcinogenesis 1997;18:1549-53
   PubMed Web of Science ®Google Scholar
• Mann S. Melatonin for ulcerative colitis? Am J Gastroenterol 2003;98:232-3
   Google Scholar
• Mazzon E, Esposito E, Crisafulli C, et al. Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. J Pineal Res 2006;41:363-73
   Google Scholar
• Melen-Mucha G, Winczyk K, Pawlikowski M. Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine Colon 38 cancer. Anticancer Res 1998;18:3615-20
   PubMed Web of Science ®Google Scholar
• Wenzel U, Nickel A, Daniel H. Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products. Int J Cancer 2005;116:236-42
   Google Scholar
• Farriol M, Venereo Y, Orta X, et al. In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line. J Appl Toxicol 2000;20:21-4
   Web of Science ®Google Scholar
• Lewinski A, Rybicka I, Wajs E, et al. Influence of pineal indolamines on the mitotic activity of gastric and colonic mucosa epithelial cells in the rat: interaction with omeprazole. J Pineal Res 1991;10:104-8
   Google Scholar
• García-Navarro A, González-Puga C, Escames G, et al. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res 2007;43:195-205
   PubMedGoogle Scholar
• Anisimov VN, Popovich IG, Shtylik AV, et al. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Exp Toxicol Pathol 2000;52:71-6
   PubMedGoogle Scholar
• Winczyk K, Pawlikowski M, Karasek M. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer. J Pineal Res 2001;31:179-82
   Google Scholar
• Wiesenberg I, Missbach M, Carlberg C. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 1998;12:143-50
   PubMed Web of Science ®Google Scholar
• Carpentieri A, Díaz de Barboza G, Areco V, et al. New perspectives in melatonin uses. Pharmac Res 2012;65(4):437-44
   Google Scholar
• Wang J, Guo W, Chen W, et al. Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways. J Pineal Res 2013;54:406-16
   Google Scholar
• Ozdemir F, Deniz O, Kaynar K, et al. The effects of melatonin on human hepatoma (Hep G2) cell line. Bratisl Lek Listy 2009;110:276-9
   Google Scholar
• Martín-Renedo J, Mauriz JL, Jorquera F, et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008;45:532-40
   PubMed Web of Science ®Google Scholar
• Carbajo-Pescador S, Steinmetz C, Kashyap A, et al. Melatonin induces transcriptional regulation of Bim by Fox03a in HepG2 cells. Br J Cancer 2012;108:442-9
   Google Scholar
• Zha L, Fan L, Sun G, et al. Melatonin sensitizes human hepatoma cells to endoplasmic reticulum stress-induced apoptosis. J Pineal Res 2012;52:322-31
   PubMed Web of Science ®Google Scholar
• Fan LL, Sun GP, Wei W, et al. Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J Gastroenterol 2010;16:1473-81
   PubMed Web of Science ®Google Scholar
• Blask DE, Dauchy RT, Sauer LA, et al. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Carcinogenesis 2004;25:951-60
   PubMed Web of Science ®Google Scholar
• Glasgow WC, Hui R, Everhart AL, et al. The linoleic acid metabolite, (13s)-hydroxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of receptor dephosphorylation. J Biol Chem 1997;272:19269-76
   PubMedGoogle Scholar
• Malmlöf M, Roudier E, Högberg J, Stenius U. MEK-ERK-mediated phosphorylation of Mdm2 at Ser-166 in hepatocytes. Mdm2 is activated in response to inhibited Akt signaling. J Biol Chem 2007;282:2288-96
   Google Scholar
• Yang JY, Zong CS, Xia W, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008;10:138-48
   PubMed Web of Science ®Google Scholar
• Padillo FJ, Ruiz-Rabelo JF, Cruz A, et al. Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer. J Pineal Res 2010;49:264-70
   Google Scholar
• Han Y, Demorrow S, Invernizzi P, et al. Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth. Am J Physiol Gastroint Liver Physiol 2011;301:G623-33
   PubMed Web of Science ®Google Scholar
• Laothong U, Pinlaor P, Boonsiri P, et al. Melatonin inhibits cholangiocarcinoma and reduces liver injury in opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters. J Pineal Res 2013; In press
   Google Scholar
• Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010;49:248-55
   PubMed Web of Science ®Google Scholar
• González A, del Castillo-Vaquero A, Miro-Moran A, et al. Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology. J Pineal Res 2011;50:250-60
   Google Scholar
• Xu C, Wu A, Zhu H, et al. Melatonin is involved in the apoptosis and necrosis of pancreatic cancer cell line SW-1990 via modulating of Bcl-2/Bax balance. Biomed Pharmacother 2013;67:133-9
   Google Scholar
• Glenister R, McDaniel K, Francis H, et al. Therapeutic actions of melatonin on gastrointestinal cancer development and progression. Transl Gastrointest Cancer 2013;2:11-20
   Google Scholar
• Zhang S, Qi Y, Zhang H. Melatonin inhibits cell growth and migration, but promotes apoptosis in gastric cancer cell line, SGC7901. Biotech Histochem 2013;1-9
   Google Scholar
• Xu L, Liu H, Zhang H, et al. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism. Anat Rec (Hoboken) 2013;296:914-20
   Google Scholar
• El-Missiry MA, Abd El-Aziz A. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells. Cancer Lett 2000;151:119-25
   PubMed Web of Science ®Google Scholar
• García-Santos G, Martin V, Rodriguez-Blanco J, et al. Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin. Br J Cancer 2012;106:1288-96
   Google Scholar
• Cheng Y, Cai L, Jiang P, et al. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. Eur J Pharmacol 2013; In press
   Google Scholar
• Min KJ, Kim HS, Park EJ, Kwon TK. Melatonin enhances thapsigargin-induced apoptosis through reactive oxygen species-mediated upregulation of CCAAT-enhancer-binding protein homologous protein in human renal cancer cells. J Pineal Res 2012;53:99-106
   Google Scholar
• Cos S, Garcia-Bolado A, Sánchez-Barceló EJ. Direct antiproliferative effects of melatonin on two metastatic cell sublines of mouse melanoma (B16BL6 and PG19). Melanoma Res 2001;11:197-201
   Google Scholar
• Yerneni LK, Jayaraman S. Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure. Melanoma Res 2003;13:113-17
   Google Scholar
• Helton RA, Harrison WA, Kelley K, Kane MA. Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res 1993;3:403-13
   PubMed Web of Science ®Google Scholar
• Mengeaud V, Skene D, Pévet P, Ortonne JP. No high affinity melatonin binding sites are detected in murine melanoma cells and in normal human melanocytes cultured in vitro. Melanoma Res 1994;4:87-91
   Google Scholar
• Slominski A, Pruski D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993;206:189-94
   PubMed Web of Science ®Google Scholar
• Bejarano I, Espino J, Barriga C, et al. Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects. Basic Clin Pharmacol Toxicol 2011;108:14-20
   PubMed Web of Science ®Google Scholar
• González A, Martínez-Campa C, Mediavilla MD, et al. Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells. Br J Cancer 2007;97:755-60
   Google Scholar
• García-Santos G, Antolín I, Herrera F, et al. Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006;41:130-5
   PubMed Web of Science ®Google Scholar
• Martín V, García-Santos G, Rodriguez-Blanco J, et al. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death. Cancer Lett 2010;287:216-23
   PubMed Web of Science ®Google Scholar
• Ji YL, Wang H, Meng C, et al. Melatonin alleviates cadmium-induced cellular stress and germ cell apoptosis in testes. J Pineal Res 2012;52:71-9
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu D, Wang J, et al. Cytoprotective effects of melatonin on astroglial cells subjected to palmitic acid treatment in vitro. J Pineal Res 2012;52:253-64
   PubMed Web of Science ®Google Scholar
• Pandey S, Lopez C, Jammu A. Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells; inhibition of cell death by melatonin. Apoptosis 2003;8:497-508
   PubMed Web of Science ®Google Scholar
• McCartney-Francis NL, Wahl SM. Transforming growth factor beta: a matter of life and death. J Leukocyte Biol 1994;55:401-9
   PubMed Web of Science ®Google Scholar
• Lanoix D, Lacasse AA, Reiter RJ, Vaillancourt C. Melatonin: the smart killer: the human trophoblast as a model. Mol Cell Endocrinol 2012;348:1-11
   PubMed Web of Science ®Google Scholar
• Von Bertalanffy L. The theory of open systems in physics and biology. Science 1950;111:23-9
   PubMed Web of Science ®Google Scholar
• Bizzarri M, Palombo A, Cucina A. Theoretical aspects of systems biology. Prog Biophys Mol Biol 2013;112:33-43
   PubMed Web of Science ®Google Scholar
• Sakagami H, Satoh K, Hakeda Y, Kumegawa M. Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol (Noisy-le-grand) 2000;46:129-43
   PubMed Web of Science ®Google Scholar
• Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci 2002;957:210-29
   PubMed Web of Science ®Google Scholar
• Gunawardena K, Murray DK, Meikle AW. Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate 2000;44:287-95
   Google Scholar
• Martín V, Herrera F, Carrera-Gonzalez P, et al. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res 2006;66:1081-8
   PubMed Web of Science ®Google Scholar
• Greene MW. Circadian rhythms and tumor growth. Cancer Lett 2012;318:115-23
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Numano R, Abe M. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000;288:682-5
   PubMed Web of Science ®Google Scholar
• Dauchy RT, Blask DE, Sauer LA, et al. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 1999;144:131-6
   Google Scholar
• Reiter RJ, Tan DX, Korkmaz A, et al. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit Rev Oncog 2007;13:303-28
   PubMedGoogle Scholar
• Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2002;2:113-32
   PubMedGoogle Scholar
• Zeman M, Szantoova K, Stebelova K, et al. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats. J Hypertens 2009;27(Suppl 6):S21-6
   Google Scholar
• Jung-Hynes B, Reiter RJ, Ahmad N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 2010;48:9-19
   PubMed Web of Science ®Google Scholar
• Chen ST, Choo KB, Hou MF, et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005;26:1241-6
   PubMed Web of Science ®Google Scholar
• You S, Wood PA, Xiong Y, et al. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat 2005;91:47-60
   PubMed Web of Science ®Google Scholar
• Akagi T, Ushinohama K, Ikesue S, et al. Chronopharmacology of melatonin in mice to maximize the antitumor effect and minimize the rhythm disturbance effect. J Pharmacol Exp Ther 2004;308:378-84
   PubMed Web of Science ®Google Scholar
• Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011;51:1-16
   PubMed Web of Science ®Google Scholar
• Galano A, Tan DX, Reiter RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013;54:245-57
   PubMed Web of Science ®Google Scholar
• Osseni RA, Rat P, Bogdan A, et al. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000;68:387-99
   PubMed Web of Science ®Google Scholar
• Buyukavci M, Ozdemir O, Buck S, et al. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fund Clin Pharmacol 2006;20:73-9
   PubMed Web of Science ®Google Scholar
• Matés JM, Segura JA, Alonso FJ, Márquez J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 2008;82:273-99
   PubMed Web of Science ®Google Scholar
• Sánchez-Sánchez AM, Martín V, García-Santos G, et al. Intracellular redox state as determinant for melatonin antiproliferative vs. cytotoxic effects in cancer cells. Free Radic Res 2011;45:1333-41
   PubMed Web of Science ®Google Scholar